<DOC>
	<DOCNO>NCT01118923</DOCNO>
	<brief_summary>The present study part project title 'Magnesium asthma chronic obstructive pulmonary disease ' . The hypothesis main project daily magnesium supplement benefit patient asthma chronic obstructive pulmonary disease . The aim part project study effect daily magnesium supplement grade bronchial hyperreactivity asthmatic .</brief_summary>
	<brief_title>Bronchial Challenge Test Magnesium-treated Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<criteria>Asthma annual symptom , bronchial hyperreactivity positive metacholinetest ( PD20 &lt; 1000 microgram SeMg &gt; 2,00 mmol/L , smoke cessation le 1 year prior study start , major change eat habit within three month prior study start study period approx . one year , various condition ( e.g . gastrointestinal disease , kidney disease , pregnancy/lactation ) may affect study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Bronchial challenge test</keyword>
	<keyword>Hyperreactivity</keyword>
	<keyword>PD20 metacholine</keyword>
	<keyword>Daily magnesium supplement</keyword>
</DOC>